Andreas Spiro
Contributor since: 2012
Marijuana Stocks - The Good, The Bad And The Ugly
After Bristol Myers' Bydureon Success, The Next Step Is Sustained Release Insulin
A New Trial Combining Fabrus And Senseco Technologies May Be Close At Hand
3 Approaches To Retinitis Pigmentosa
Will Apoptosis Succeed Where Other Cancer Treatments Haven't? Three Companies Trying
The Fed Walks Into Two Sports Bars: Buffalo Wild Wings And Hooters Redux
How Cyprus Could Cause Hyperinflation, And How Agriculture Can Save You
The Business Of Electronic Health Records
4 Cancer Treatments On The Way Up
Better Place Failure Teaches Lessons To EV Investors
The Cream Of The Gold Crop
Coffee, Doughnuts, And Soup For Investors Of All Different Tastes
New Studies Create Buzz Over Bee Plague Antidotes
Is Holy Grail Of Local Mobile Marketing In Sight?
Car Charging's Battle Against 'Range Anxiety'
Will The Sanofi Pompe Paradigm Play Out With Neuralstem And Lou Gehrig's Disease?
What Do Ron Paul, Northwest Biotherapeutics, And Novartis Have In Common?
A David In The Chinese Goliath Education Market
First Merck, Then Bausch And Lomb, Who's Next To Partner With InSite Vision?
Applying Jim Rogers' Thought To Implant Sciences And The Defense Industry